Ai Maeda

1.2k total citations
39 papers, 848 citations indexed

About

Ai Maeda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Ai Maeda has authored 39 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 7 papers in Pharmacology. Recurrent topics in Ai Maeda's work include Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Ai Maeda is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Ai Maeda collaborates with scholars based in Japan, Sweden and Germany. Ai Maeda's co-authors include Masao Nakata, Katsuhiko Shimizu, Shinsuke Saisho, Riki Okita, Takuro Yukawa, Yuji Nojima, Yuji Hirami, Kazuo Tanemoto, Koichiro Yasuda and Mikio Oka and has published in prestigious journals such as PLoS ONE, The Annals of Thoracic Surgery and Oncotarget.

In The Last Decade

Ai Maeda

36 papers receiving 821 citations

Peers

Ai Maeda
Dalin Li China
Brian S. Henick United States
Gen Lin China
Gayathri Anandappa United Kingdom
David B. Page United States
Danny Nguyen United States
Dalin Li China
Ai Maeda
Citations per year, relative to Ai Maeda Ai Maeda (= 1×) peers Dalin Li

Countries citing papers authored by Ai Maeda

Since Specialization
Citations

This map shows the geographic impact of Ai Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ai Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ai Maeda more than expected).

Fields of papers citing papers by Ai Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ai Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ai Maeda. The network helps show where Ai Maeda may publish in the future.

Co-authorship network of co-authors of Ai Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Ai Maeda. A scholar is included among the top collaborators of Ai Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ai Maeda. Ai Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Katsuhiko, Riki Okita, Shinsuke Saisho, et al.. (2018). Impact of COX2 Inhibitor for Regulation of PD-L1 Expression in Non-small Cell Lung Cancer. Anticancer Research. 38(8). 4637–4644. 25 indexed citations
2.
Shimizu, Katsuhiko, Riki Okita, Shinsuke Saisho, et al.. (2017). Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma. Cancer Management and Research. Volume 9. 741–750. 17 indexed citations
3.
Shimizu, Katsuhiko, Riki Okita, Shinsuke Saisho, et al.. (2017). Urinary levels of prostaglandin E2 are positively correlated with intratumoral infiltration of Foxp3+ regulatory T cells in non-small cell lung cancer. Oncology Letters. 14(2). 1615–1620. 6 indexed citations
4.
Maeda, Ai, Masao Nakata, Katsuhiko Shimizu, et al.. (2016). Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report. World Journal of Surgical Oncology. 14(1). 175–175. 7 indexed citations
5.
Okita, Riki, Takuro Yukawa, Yuji Nojima, et al.. (2016). MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer. Cancer Immunology Immunotherapy. 65(5). 499–509. 54 indexed citations
6.
Shimizu, Katsuhiko, Takuro Yukawa, Riki Okita, et al.. (2015). Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy. World Journal of Surgical Oncology. 13(1). 21–21. 16 indexed citations
7.
Shimizu, Katsuhiko, Riki Okita, Shinsuke Saisho, et al.. (2015). Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer. Therapeutics and Clinical Risk Management. 11. 1555–1555. 21 indexed citations
8.
Yukawa, Takuro, Katsuhiko Shimizu, Ai Maeda, et al.. (2014). Cyclooxygenase-2 genetic variants influence intratumoral infiltration of Foxp3-positive regulatory T cells in non-small cell lung cancer. Oncology Reports. 33(1). 74–80. 9 indexed citations
9.
Shimizu, Katsuhiko, Ai Maeda, Takuro Yukawa, et al.. (2014). Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma. World Journal of Surgical Oncology. 12(1). 343–343. 12 indexed citations
10.
Saisho, Shinsuke, Koichiro Yasuda, Ai Maeda, et al.. (2013). Role of 2-[18F]fluoro-2-deoxyglucose positron emission tomography in preoperative management of solid-type small-sized lung cancer. Annals of Nuclear Medicine. 27(6). 515–522. 3 indexed citations
11.
Yukawa, Takuro, Katsuhiko Shimizu, Yuji Hirami, et al.. (2013). A case report of intrapulmonary schwannoma. General Thoracic and Cardiovascular Surgery. 62(4). 252–254. 10 indexed citations
12.
Yasuda, Koichiro, Ai Maeda, Takuro Yukawa, et al.. (2012). Case of pleural metastasis of prostate cancer. Thoracic Cancer. 4(4). 465–468. 2 indexed citations
13.
Shimizu, Katsuhiko, Yuji Hirami, Shinsuke Saisho, et al.. (2012). Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients. World Journal of Surgical Oncology. 10(1). 141–141. 12 indexed citations
14.
Shimizu, Katsuhiko, Takuro Yukawa, Yuji Hirami, et al.. (2012). Heterogeneity of the EGFR mutation status between the primary tumor and metastatic lymph node and the sensitivity to EGFR tyrosine kinase inhibitor in non-small cell lung cancer. Targeted Oncology. 8(4). 237–242. 24 indexed citations
15.
Maeda, Ai, Masao Nakata, Koichiro Yasuda, et al.. (2012). Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis. Oncology Reports. 29(1). 39–44. 24 indexed citations
16.
Shimizu, Katsuhiko, Yuji Hirami, Shinsuke Saisho, et al.. (2011). Maximal Standardized Uptake Value on FDG-PET Is Correlated With Cyclooxygenase-2 Expression in Patients With Lung Adenocarcinoma. The Annals of Thoracic Surgery. 93(2). 398–403. 9 indexed citations
17.
Maeda, Ai, Katsuhiko Shimizu, Takuro Yukawa, Yuji Hirami, & Masao Nakata. (2010). A case of aberrant mediastinal goiter. The Journal of the Japanese Association for Chest Surgery. 24(2). 195–199. 2 indexed citations
18.
Yukawa, Takuro, Katsuhiko Shimizu, Yuji Hirami, Ai Maeda, & Masao Nakata. (2010). A case report of solitary plasmacytoma of the sternum. The Journal of the Japanese Association for Chest Surgery. 24(2). 242–246.
19.
Shimizu, Katsuhiko, Masao Nakata, Yuji Hirami, et al.. (2010). Tumor-Infiltrating Foxp3+ Regulatory T Cells are Correlated with Cyclooxygenase-2 Expression and are Associated with Recurrence in Resected Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(5). 585–590. 205 indexed citations
20.
Maeda, Ai. (2004). Text and the City. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026